After exclusion of the patients with HER2-positive disease, we still observe a significantly worse RFI in patients with high CD8 expression in the tumor microenvironment (HRhigh-CD8 = 1.87; 95% CI 1.07–3.28, p < 0.0001). The gene discussed is CD8A; the disease is neoplasm.